We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Coagulation Monitoring Moves Towards POC Testing in Europe

By HospiMedica staff writers
Posted on 28 Aug 2007
In Europe, coagulation monitoring is moving towards point-of-care (POC) testing, which ensures quick generation of results and better patient care.

Coagulation testing is a common practice used for patients under oral anticoagulation therapy as well as those undergoing cardiac surgeries including cardiopulmonary bypass surgery. More...
The early monitoring of anticoagulants during or before surgery is crucial as it enables surgeons and physicians to control the level of bleeding.

Research analyst Gayathry Ramachandran, from Frost & Sullivan (Palo Alto, CA, USA), an international growth consultancy company, noted "POC coagulation tests have made life simpler, as they enable patients to be well informed about the disease state, thus boosting patient confidence and reducing hospital visits.”

With the increase in the number of patients under anticoagulant therapy, it is very important to closely monitor the prothrombin time (PT) and the international standardized ratio (INR). This is being achieved by installing POC instruments in emergency units, outpatient wards as well as patient homes to enable self-testing. This reduces the burden on hospitals as well as physician offices and prevents dangerous effects of anticoagulants and other bleeding disorders.

The growth of POC is generated by quick turn-around-times (TAT) and easy-to-use technology. At the same time, laboratory tests continue to be preferred in some European countries since they are cost-effective and well reimbursed when compared to POC tests.

Presently, laboratory tests generate delayed results and do not support fast treatment processes. Hence, there is a need to produce timely results that will result in improved patient care. With an increasing number of tests moving towards POC, the volume of tests in laboratories is adversely affected. To overcome this challenge, laboratories are slowly adopting high-volume analyzers to perform special coagulation tests, which have not yet reached the POC market.

"The laboratory testing arena is facing challenges related to the lack of qualified lab personnel,” explained Ms. Ramachandran. "Tests conducted in the laboratories by non-laboratory personnel are giving rise to inappropriate quality control.”

In this situation, it is crucial to maintain international quality in the results of laboratory and POC tests. The most effective strategy is to conduct training programs for laboratory and non-laboratory personnel to maintain the high quality of results. This should include instrument handling and patient preparation, among others.


Related Links:
Frost and Sullivan

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hybrid Arch Device
Neo EDE
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.